Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Inorg Chem ; 60(24): 18822-18831, 2021 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-34855391

RESUMO

The complex [PtMe(Obpy)(OAc)2(H2O)], 2a, Obpy = 2,2'-bipyridine N-oxide, is prepared through the reaction of [PtMe(Obpy)(SMe2)], 1a, by 1 equiv of PhI(OAc)2 via an oxidative addition (OA) reaction. Pt(IV) complex 2a attends the process of C-O bond reductive elimination (RE) reaction to form methyl acetate and corresponding Pt(II) complex [Pt(Obpy)(OAc)(H2O)], 3a. The kinetic of OA and RE reactions are investigated by means of different spectroscopies. The obtained results show that the reaction rates of OA step of 1a are faster than its analogous complex [PtMe(ppy)(SMe2)], 1b, ppy = 2-phenylpyridine. The density functional theory (DFT) calculations signify that the OA reaction initiated by a nucleophilic attack of the platinum(II) central atom of 1b on the iodine(III) atom while it had commenced by a nucleophilic substitution reaction of coordinated SMe2 in 1a with a carbonyl oxygen atom of PhI(OAc)2. Our calculation revealed that the key step for 1a is an acetate transfer from the I(III) to Pt(II) through a formation of square pyramidal iodonium complex. This can be attributed to the more electron-withdrawing character of Obpy ligand than to ppy which reduces the nucleophilicity of Pt atom in 1a. Furthermore, 2a with electron-withdrawing Obpy ligand prone to C-O bond formation faster than complex [PtMe(ppy)(OAc)2(H2O)], 2b, with an electron-rich ppy ligand which conforms to the anticipation that REs occur faster on electron-poor metal centers.

2.
Bioorg Med Chem ; 28(8): 115408, 2020 04 15.
Artigo em Inglês | MEDLINE | ID: mdl-32165076

RESUMO

This article reports for the first time the synthesis of some novel ß-lactam morpholino-1,3,5-triazine hybrids by a [2+2]-cycloaddition reaction of imines 7a-c, 9a-c and 11 with ketenes derived from substituted acetic acids. The reaction was totally diastereoselective, leading exclusively to the formation of cis-ß-lactams 8a-l, 10a-f and 12a-c. The synthesized compounds were tested for activity towards SW1116, MCF-7 and HepG2 cancer cell lines and non-cancerous HEK-293 cell line by MTT assay. None of the compounds exert an observable effect on HepG2, MCF-7 and HEK-293 cells, but compounds 7b, 8f, 8g, 8l, 10c, and 10e exhibited excellent growth inhibitory activity (IC50 < 5 µM) against SW 1116 cells, comparable to that of doxorubicin (IC50 = 6.9 µM). An evaluation of the antioxidant potential of each of the compounds, performed by diphenylpicrylhydrazyl (DPPH) assay, indicated that 7b, 9a, 9b and 9c have strong free radical scavenging activity. UV absorption titration studies reveal that 7b, 8l, 8g and 8f interact strongly with calf-thymus DNA (CT-DNA) in the order of 8l > 7b > 8f > 8g. Collectively, the in vitro capabilities of some of these morpholino-triazine imines and ß-lactams suggest possible applications to development of new antioxidants and DNA binding therapeutics.


Assuntos
Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Desenho de Fármacos , Triazinas/farmacologia , beta-Lactamas/farmacologia , Antineoplásicos/síntese química , Antioxidantes/síntese química , Linhagem Celular , Concentração Inibidora 50 , Modelos Moleculares , Estrutura Molecular , Relação Estrutura-Atividade , Triazinas/química , beta-Lactamas/síntese química
3.
Organometallics ; 33(17): 4353-4356, 2014 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-25221379

RESUMO

Reaction of a complex Pt organometallic species with electrophilic halogen sources in the presence of X- ligands changes the mechanism of reductive elimination from a concerted reductive coupling type to an SN2 type reductive elimination. In the absence of the added X- ligand the reductive elimination is stereoretentive; in its presence, the process is stereoinvertive. This selectivity hinges on the reactivity of a key five-coordinate Pt(IV) intermediate with the X- ligand.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA